Cancer vaccine approved29th September 2006
The European Union has approved Gardasil, the vaccine for cervical cancer. The UK Joint Committee on Vaccination and Immunisation will now advise the Department of Health whether it should be made available in the NHS.
Gardasil works against human papillomavirus types 6, 11, 16, and 18, which can lead to cervical cancer; it is designed to be given to girls and women aged 9 to 26 years.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Cancer vaccine approved
Author: Sue Knights
Article Id: 839
Date Added: 29th Sep 2006